AR019997A1 - Sistema de administracion topica para agentes activos - Google Patents

Sistema de administracion topica para agentes activos

Info

Publication number
AR019997A1
AR019997A1 ARP990103865A ARP990103865A AR019997A1 AR 019997 A1 AR019997 A1 AR 019997A1 AR P990103865 A ARP990103865 A AR P990103865A AR P990103865 A ARP990103865 A AR P990103865A AR 019997 A1 AR019997 A1 AR 019997A1
Authority
AR
Argentina
Prior art keywords
agents
active agents
topical administration
administration system
hair
Prior art date
Application number
ARP990103865A
Other languages
English (en)
Original Assignee
Johnson & Johnson Consumer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer filed Critical Johnson & Johnson Consumer
Publication of AR019997A1 publication Critical patent/AR019997A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0291—Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A61K8/355—Quinones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/90—Block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invencion se refiere a un método para mejorar la penetracion transmembrana de agentes beneficiosos utilizando una cierta formulacion quecontiene agentes tensioactivos/lipídicos noionicos como agente mejorador, y las composiciones allí usadas. Varios agentes activos, tales como agentesanticaspa, agentes para el crecimiento del cabello, agentes inhibidores del cabello, agentes anti-acné, agentes anti-envejecimiento, agentes depilatoriosy agentes de despigmentacion, pueden administrarse sobrela piel, los folículos del cabello y las glándulas sebáceas utilizando las composicionesde la presente invencion.
ARP990103865A 1998-08-04 1999-08-03 Sistema de administracion topica para agentes activos AR019997A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9528998P 1998-08-04 1998-08-04
US09/360,412 US6284234B1 (en) 1998-08-04 1999-07-23 Topical delivery systems for active agents

Publications (1)

Publication Number Publication Date
AR019997A1 true AR019997A1 (es) 2002-03-27

Family

ID=26790038

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990103865A AR019997A1 (es) 1998-08-04 1999-08-03 Sistema de administracion topica para agentes activos

Country Status (10)

Country Link
US (2) US6284234B1 (es)
EP (1) EP1104280A2 (es)
JP (1) JP2003521452A (es)
CN (1) CN1303263A (es)
AR (1) AR019997A1 (es)
AU (1) AU5669599A (es)
CA (1) CA2339231A1 (es)
CO (1) CO5080786A1 (es)
TW (1) TWI257310B (es)
WO (1) WO2000007627A2 (es)

Families Citing this family (216)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7011834B1 (en) * 1987-01-30 2006-03-14 The Board Of Trustees Of Leland Stanford Junior University Immunomodulating dimers
GB9504265D0 (en) * 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
US6512010B1 (en) * 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
AUPO983897A0 (en) * 1997-10-17 1997-11-06 Soltec Research Pty Ltd Topical antifungal composition
AUPP310798A0 (en) * 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
EP1159266B1 (en) 1999-03-05 2004-11-03 Duke University C-16 unsaturated fp-selective prostaglandins analogs
DE19921794A1 (de) * 1999-05-11 2000-11-23 Hexal Ag Neue pharmazeutische Zusammensetzung
CA2309373A1 (en) * 1999-05-27 2000-11-27 Johnson & Johnson Consumer Companies, Inc. Novel topical formulations
US6762158B2 (en) * 1999-07-01 2004-07-13 Johnson & Johnson Consumer Companies, Inc. Personal care compositions comprising liquid ester mixtures
IL132625A (en) * 1999-10-28 2007-06-17 Avi Dascalu Composition for inducing hair growth
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
JP4213837B2 (ja) * 2000-02-18 2009-01-21 株式会社マンダム 育毛剤組成物
US6596266B2 (en) * 2000-02-18 2003-07-22 Natural Science, Inc. Compositions containing minoxidil and saw palmetto for treating baldness
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) * 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
AU4473001A (en) * 2000-04-07 2001-10-30 Taisho Pharmaceutical Co Ltd Hair growth stimulant compositions with sustained action
WO2001085162A1 (en) * 2000-05-12 2001-11-15 Meracol Corporation Limited Treating irritable bowel syndrome or disease
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
NZ504526A (en) * 2000-05-12 2003-05-30 Meracol Corp Ltd Treating herpes simplex symptoms using a mixture of cetyl myristate and cetyl palmitate
CA2408541C (en) * 2000-05-12 2009-07-28 Meracol Corporation Limited Treating eczema and/or psoriasis
US20050008602A1 (en) * 2000-06-05 2005-01-13 Sumitomo Electric Industries, Ltd. Oligopeptides for promoting hair growth
US7241731B2 (en) 2000-06-05 2007-07-10 Sumitomo Electric Industries, Ltd. Oligopeptides for promoting hair growth
AUPQ875700A0 (en) * 2000-07-13 2000-08-03 Reflex Research Limited Combination compositions
FR2812190B1 (fr) * 2000-07-28 2003-01-31 Oreal Utilisation d'agonistes non prostanoiques des recepteurs des prostaglandines ep-2 et/ou ep-4 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
FR2812193B1 (fr) * 2000-07-28 2003-10-24 Oreal Utilisation d'antagoniste des recepteurs des prostaglandines ep-2 et/ou ep-4 pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques
FR2812192B1 (fr) * 2000-07-28 2003-01-31 Oreal Utilisation d'antagonistes de recepteur des prostaglandines ep-3 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
FR2812191B1 (fr) * 2000-07-28 2003-10-17 Oreal Utilisation d'agonistes du recepteur des prostaglandines e2 (ep-3) pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques
US7198801B2 (en) * 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
KR100856523B1 (ko) 2000-08-03 2008-09-04 안타레스 파르마 아이피엘 에이쥐 충분한 치료효과를 보장하는 활성 화합물의 경피 및/또는경점막 투여용 신규 조성물
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
US7442369B1 (en) 2000-08-09 2008-10-28 Mcneil Ab Compositions of minoxidil
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
DE60111362T2 (de) 2000-09-08 2006-07-20 Vivier Canada Inc., Vaudreuil Stabilisierte ascorbinsäure-lösungen
US6562321B2 (en) * 2000-12-20 2003-05-13 Avon Products, Inc. Compositions and methods for treating hyperpigmentation
US20040067245A1 (en) * 2000-12-20 2004-04-08 Harish Mahalingam Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin
KR100423666B1 (ko) * 2001-02-07 2004-03-18 보령제약 주식회사 항진균 외용 제제
JP2003012468A (ja) * 2001-06-28 2003-01-15 Kaminomoto Co Ltd 養毛・発毛促進剤
ATE406867T1 (de) * 2001-07-18 2008-09-15 Unilever Nv Zusammensetzungen für die behandlung von haaren und/oder kopfhaut
US6866841B2 (en) 2001-08-09 2005-03-15 Epatentmanager.Com Non-endocrine disrupting cytoprotective UV radiation resistant substance
US7261878B2 (en) * 2001-08-10 2007-08-28 The Gillette Company Reduction of hair growth
US20030036561A1 (en) * 2001-08-10 2003-02-20 Peter Styczynski Reduction of hair growth
US20070238697A1 (en) * 2001-08-29 2007-10-11 University Of British Columbia Pharmaceutical compositions and methods relating to fucans
JP2003113023A (ja) * 2001-09-28 2003-04-18 Shiseido Co Ltd 皮膚外用剤用基剤及びそれを配合してなる化粧品
DE60137978D1 (de) * 2001-09-28 2009-04-23 Lg Household & Health Care Ltd Zusammensetzung zur förderung des haarwachstums
US7625574B2 (en) * 2001-09-28 2009-12-01 Shiseido Research Center Skin treatment composition
SE0104421D0 (sv) 2001-12-21 2001-12-21 Ponsus Pharma Ab New composition
US20040198821A1 (en) * 2002-01-29 2004-10-07 Hwang Cheng Shine Reduction of hair growth
US7160921B2 (en) * 2002-01-29 2007-01-09 The Gillette Company Reduction of hair growth
US20030199584A1 (en) * 2002-04-11 2003-10-23 Ahluwalia Gurpreet S. Reduction of hair growth
US7241808B2 (en) * 2002-05-01 2007-07-10 Marvin Klein Composition for treatment of skin and method for stabilizing the composition
US20030232091A1 (en) * 2002-06-17 2003-12-18 Adi Shefer Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof
SI21258A (sl) 2002-07-17 2004-02-29 LEK farmacevtska dru�ba d.d. Stabilni farmacevtski pripravek, ki vsebuje eritropoietin in poloksamerni poliol
DE10240029A1 (de) * 2002-08-27 2004-03-11 Beiersdorf Ag Wirkstoffkombinationen aus Climbazol, Pirocton olamin und Undecylenamidopropylbetain sowie kosmetische oder dermatologische Zubereitungen, solche Wirkstoffkombinationen enthaltend
US8900607B1 (en) 2002-09-25 2014-12-02 Chemsil Silicones, Inc. Clear, greaseless skin-care compositions
US20040086471A1 (en) * 2002-10-31 2004-05-06 Lin Connie Baozhen Compositions for darkening the skin and/or hair
US7939489B2 (en) * 2002-12-23 2011-05-10 Avon Products, Inc. Oil absorbent topical compositions and methods for using same
US20040141935A1 (en) * 2003-01-21 2004-07-22 Peter Styczynski Reduction of hair growth
NZ541526A (en) * 2003-01-24 2008-03-28 Stiefel Res Australia Pty Ltd Clindamycin phosphate foam
EP1594484A2 (en) * 2003-02-17 2005-11-16 Cipla Ltd. Pharmaceutical patch
US7015349B2 (en) 2003-03-26 2006-03-21 The Gillette Company Reduction of hair growth
US7186416B2 (en) * 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
US20050037046A1 (en) * 2003-07-31 2005-02-17 Ken Braun Fish attractant and applicator
MXPA06002701A (es) * 2003-09-10 2006-06-06 Procter & Gamble Composicion para el cuidado de la piel.
JP5619337B2 (ja) 2003-10-10 2014-11-05 フェリング ビー．ブイ． 皮膚残渣を最小限に抑えるための経皮的医薬製剤
US20050095215A1 (en) * 2003-11-03 2005-05-05 Popp Karl F. Antimicrobial shampoo compositions
US20050112075A1 (en) * 2003-11-25 2005-05-26 Hwang Cheng S. Reduction of hair growth
FR2863174B1 (fr) * 2003-12-08 2006-11-24 Galderma Res & Dev Dispositif de dosage d'un produit destine a etre applique sur la peau
US20050132466A1 (en) * 2003-12-11 2005-06-23 Kimberly-Clark Worldwide, Inc. Elastomeric glove coating
US20050127552A1 (en) 2003-12-11 2005-06-16 Kimberly-Clark Worldwide, Inc. Method for forming an elastomeric article
US7935331B2 (en) * 2003-12-12 2011-05-03 Johnson & Johnson Consumer Companies, Inc. Vanillin polymers for use in darkening the skin
US20050136015A1 (en) * 2003-12-17 2005-06-23 McKie Derrick B. Topical use of halosalicylic acid derivatives
US20070086977A1 (en) * 2003-12-22 2007-04-19 Stockel Richard F Method of treating dermatological conditions
US20050163811A1 (en) * 2004-01-23 2005-07-28 Richard Lee Topical solutions comprising high concentrations of piperidinopyrimidine derivatives and methods of use thereof
DE102004004509B4 (de) * 2004-01-23 2010-07-01 Epoplus Gmbh Co.Kg Einsatz von niedrig dosiertem Erythropoietin zur Stimulation endothelialer Vorläuferzellen sowie zur Organregeneration und Progressionsverlangsamung von Endorganschäden
US20050196371A1 (en) * 2004-03-08 2005-09-08 L'oreal Aqueous composition based on alcohol, surfactant and solubilizing agent, article impregnated with this composition, and method for cleansing the hair
US20050249685A1 (en) * 2004-04-27 2005-11-10 Natalia Botchkareva Reduction of hair growth
US7425340B2 (en) * 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
US20060121073A1 (en) * 2004-07-12 2006-06-08 Sandhya Goyal Topical gel formulation comprising insecticide and its preparation thereof
US8158139B2 (en) * 2004-07-12 2012-04-17 Taro Pharmaceuticals North America, Inc. Topical gel formulation comprising organophosphate insecticide and preparation thereof
WO2006017263A1 (en) * 2004-07-12 2006-02-16 Taro Pharmaceutical Industries Ltd. Topical gel formulation comprising organophosphate insecticide and its preparation thereof
JP2008507522A (ja) * 2004-07-23 2008-03-13 ザ プロクター アンド ギャンブル カンパニー フラボノイドとビタミンｂ３を含有するスキンケア組成物
EP1773287A1 (en) * 2004-07-23 2007-04-18 The Procter and Gamble Company Substrate based skin care device
US20060018861A1 (en) * 2004-07-23 2006-01-26 Minghua Chen Skin care composition
EP1778177A1 (en) * 2004-07-23 2007-05-02 The Procter and Gamble Company Skin care composition containing a flavonoid and vitamin b3
US20060057075A1 (en) * 2004-08-02 2006-03-16 Moshe Arkin Pharmaceutical and cosmeceutical wash-off mousse shampoo compositions, processes for preparing the same and uses thereof
US20060034779A1 (en) * 2004-08-02 2006-02-16 Agis Industries (1983) Ltd. Foamable compositions containing vitamin D3 analogues, processes for preparing same and methods of treatment utilizng same
US7704522B2 (en) * 2004-09-08 2010-04-27 Clyde Morgan Topical medicament
ES2729826T3 (es) * 2004-09-23 2019-11-06 Arc Medical Devices Inc Composiciones farmacéuticas y métodos relacionados para inhibir adherencias fibrosas o enfermedad inflamatoria usando fucanos con bajo contenido de sulfato
US7423064B2 (en) * 2004-09-24 2008-09-09 Olatec Industries, Llc Composition for treating bacterial, viral, fungal diseases, inflammation and pain
JP2008519764A (ja) * 2004-11-09 2008-06-12 イマジナティブ リサーチ アソシエィツ インコーポレーテッド レチノイド溶液及びそれからつくった調合物
US7619008B2 (en) * 2004-11-12 2009-11-17 Kimberly-Clark Worldwide, Inc. Xylitol for treatment of vaginal infections
US20060106117A1 (en) * 2004-11-12 2006-05-18 Kimberly-Clark Worldwide, Inc. Compound and method for prevention and/or treatment of vaginal infections
WO2006058430A1 (en) * 2004-12-02 2006-06-08 Testa Hair Holdings Inc. Composition for treating hair and scalp and method for preparing same
AU2005319166A1 (en) * 2004-12-22 2006-06-29 The Gillette Company Reduction of hair growth with survivin inhibitors
US20070032781A1 (en) * 2004-12-22 2007-02-08 Henry James P Reduction of hair growth
EP1827371A2 (en) * 2004-12-22 2007-09-05 The Gillette Company Reduction of hair growth
US20060177392A1 (en) * 2005-02-10 2006-08-10 William Walden Oil-based composition for acne
MX2007010881A (es) * 2005-03-10 2007-12-05 Jr Chem Llc Composiciones de peroxido de benzoilo y metodos de uso.
CA2600762C (en) * 2005-03-10 2011-05-31 Jr Chem, Llc Stable organic peroxide compositions
US20060223765A1 (en) * 2005-03-30 2006-10-05 Kimberly-Clark Worldwide, Inc. Method for inhibiting and/or treating vaginal infection
EP1709996A1 (fr) * 2005-04-07 2006-10-11 L'oreal Composition aqueuse à base d'alcool, de tensioactif et d'agent solubilisant, article imprégné de cette composition et procédé de nettoyage des cheveux
US8034788B2 (en) * 2005-05-10 2011-10-11 Dermipsor Ltd. Composition and methods for skin care
US9173835B2 (en) 2005-05-10 2015-11-03 Dermipsor Ltd. Compositions and methods for treating hyperproliferative epidermal diseases
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
US7618956B2 (en) * 2005-05-31 2009-11-17 The Gillette Company Reduction of hair growth
PL2656860T3 (pl) 2005-06-17 2021-11-08 Wisconsin Alumni Research Foundation Preparaty środka zwężającego naczynia i sposoby ochrony komórek podczas chemioterapii i radioterapii przeciwnowotworowej
WO2007005469A2 (en) * 2005-06-29 2007-01-11 Jr Chem, Llc Method of enhanced benzoyl peroxide application
US20090306023A1 (en) * 2005-06-29 2009-12-10 Ramirez Jose E Stable organic peroxide compositions
AR054805A1 (es) * 2005-06-29 2007-07-18 Stiefel Laboratories Composiciones topicas para el tratamiento de la piel
US20070001145A1 (en) * 2005-06-29 2007-01-04 Faryniarz Joseph R Stable organic peroxide compositions
US7556820B2 (en) 2005-06-29 2009-07-07 Jr Chem, Llc Stable organic peroxide compositions
WO2007002880A2 (en) * 2005-06-29 2007-01-04 Jr Chem, Llc Method of enhanced drug application
US7560445B2 (en) 2005-07-06 2009-07-14 Taro Pharmaceuticals North America, Inc. Process for preparing malathion for pharmaceutical use
US7786176B2 (en) 2005-07-29 2010-08-31 Kimberly-Clark Worldwide, Inc. Vaginal treatment composition containing xylitol
WO2007023841A1 (ja) * 2005-08-25 2007-03-01 Taisho Pharmaceutical Co., Ltd. 発毛剤組成物
US20070071705A1 (en) * 2005-09-29 2007-03-29 De Oliveira Monica A M Topical anti-microbial compositions
PT1937276E (pt) 2005-10-12 2013-02-21 Besins Healthcare Luxembourg Gel de testosterona melhorado e método para a sua utilização
FR2892929B1 (fr) * 2005-11-09 2012-04-27 Oreal Composition cosmetique comprenant un polymere silicone structurant de phase grasse caracterisee par une durete
FR2892930B1 (fr) * 2005-11-09 2012-03-09 Oreal Composition cosmetique comprenant un polymere silicone structurant de phase grasse caracterisee par une viscosite
US8147815B2 (en) * 2005-12-16 2012-04-03 Celmatrix Corporation Topical administration carrier composition and therapeutic formulations comprising same
US9107844B2 (en) * 2006-02-03 2015-08-18 Stiefel Laboratories Inc. Topical skin treating compositions
CA2645073A1 (en) * 2006-03-08 2007-09-13 Nuviance, Inc. Transdermal drug delivery compositions and topical compositions for application on the skin
BRPI0709674A2 (pt) 2006-03-31 2011-12-06 Stiefel Res Australia Pty Ltd gel de suspensão espumante
US8399012B2 (en) 2006-04-17 2013-03-19 Kimberly-Clark Worldwide, Inc. Degradable therapeutic delivery device
CA2646667C (en) 2006-04-21 2014-03-11 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
US8703179B2 (en) * 2006-05-11 2014-04-22 Kimberly-Clark Worldwide, Inc. Mucosal formulation
WO2007137128A1 (en) 2006-05-19 2007-11-29 Mary Kay Inc. Glyceryl and glycol acid compounds
US20080008759A1 (en) * 2006-05-30 2008-01-10 Den-Mat Corporation Method of improving wound healing
NZ573248A (en) * 2006-06-01 2011-01-28 Nobera Pharma Sl Use of allopurinol (1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) for the treatment of palmar plantar erythrodysesthesia
US20080059313A1 (en) * 2006-08-30 2008-03-06 Oblong John E Hair care compositions, methods, and articles of commerce that can increase the appearance of thicker and fuller hair
US20080099168A1 (en) * 2006-10-26 2008-05-01 Kou-Chang Liu Soft and absorbent tissue products
WO2008082525A1 (en) * 2006-12-19 2008-07-10 National Stem Cell Inc Umbilical cord stem cell secreted product derived topical compositions and methods of use thereof
US20080219939A1 (en) * 2007-03-07 2008-09-11 Grune Guerry L Sunblock formulations
US20080241085A1 (en) 2007-03-29 2008-10-02 Lin Connie B Compositions for use in darkening the skin
FR2915097B1 (fr) * 2007-04-18 2012-09-28 Fabre Pierre Dermo Cosmetique Mousse antifongique a base de ciclopiroxolamine et de pyrithione de zinc et ses applications medicales et cosmetiques.
EP2455134B1 (en) 2007-04-19 2016-05-11 Mary Kay, Inc. Magnolia extract containing compositions
WO2008144157A1 (en) * 2007-04-23 2008-11-27 Transdermal Cap, Inc. Phototherapy light cap
EP2152242A1 (en) * 2007-05-21 2010-02-17 Sergeant's Pet Care Products Pest control formulation
HU227970B1 (en) 2007-07-10 2012-07-30 Egis Gyogyszergyar Nyrt Pharmaceutical compositions containing silicones of high volatility
US20090068117A1 (en) * 2007-09-04 2009-03-12 Quinnova Pharmaceuticals, Inc. Stay-on selenium foam
US20090087395A1 (en) 2007-10-01 2009-04-02 Lin Connie B Compositions for use in darkening the skin
CN101873845A (zh) * 2007-10-11 2010-10-27 麦克内尔-Ppc股份有限公司 改良的局部镇痛产品
WO2009131927A1 (en) * 2008-04-21 2009-10-29 Mcneil-Ppc, Inc. Dual spray can topical delivery device
US8729108B2 (en) * 2008-06-17 2014-05-20 Christopher J Dannaker Waterborne topical compositions for the delivery of active ingredients such as azelaic acid
WO2010006442A1 (en) * 2008-07-18 2010-01-21 Biomod Inc. Articles of manufacture releasing an active ingredient
US9750812B2 (en) * 2008-09-27 2017-09-05 Jina Pharmaceuticals, Inc. Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof
CN102256602A (zh) * 2008-10-21 2011-11-23 诺沃德米克斯国际有限公司 用于治疗上皮组织的组合物
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
WO2010093768A2 (en) * 2009-02-11 2010-08-19 Walsh Joseph F Method and preparation for treating baldness
US20150374600A1 (en) * 2009-02-11 2015-12-31 Joseph F. Walsh Methods and preparations that treat human hair loss
US20100242155A1 (en) * 2009-03-25 2010-09-30 Carullo Jr John F Headgear equipped with laser hair care apparatus
WO2010121919A1 (en) * 2009-04-23 2010-10-28 Unilever Plc Hair care composition comprising trichogen complex and an azole
US8759385B2 (en) 2009-04-23 2014-06-24 Conopco Inc. Composition comprising azole fungicide and water soluble metal salt
EP2246057A1 (en) * 2009-04-29 2010-11-03 Nobera Pharma, S.L. Use of allopurinol for the treatment of hand foot skin reaction
US8470304B2 (en) 2009-08-04 2013-06-25 Avidas Pharmaceuticals Llc Therapeutic vitamin D sun-protecting formulations and methods for their use
JP5833007B2 (ja) 2009-08-31 2015-12-16 ドクター・レディーズ・ラボラトリーズ・リミテッド ステロイドを含む局所製剤
US20110076312A1 (en) * 2009-09-29 2011-03-31 Ethicon, Inc. Antimicrobial/antibacterial medical devices coated with traditional chinese medicines
US8470880B2 (en) * 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Methods of reducing hair loss and/or facilitating hair growth and/or regrowth
US8470833B2 (en) 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Hair growth and/or regrowth compositions
US20120003300A1 (en) * 2010-06-30 2012-01-05 Pangaea Laboratories Ltd Composition Comprising Vascular Endothelial Growth Factor (VEGF) for the Treatment of Hair Loss
US20120064135A1 (en) * 2010-09-15 2012-03-15 Norac Pharma Benzoyl Peroxide Composition, Methods for Making Same, and Pharmaceutical or Cosmetic Formulations Comprising Same, and Uses Thereof
EP2438908A1 (en) 2010-10-11 2012-04-11 Vectum Pharma, S.L. Anchoring compositions for topical applications
US20120128753A1 (en) * 2010-11-18 2012-05-24 Sally Villalobos Meditowel pre-packaged medicated muscle and joint pain relief wipe
MY175521A (en) 2011-01-07 2020-07-01 Allergan Inc Melanin modification compositions and methods of use
WO2012148174A2 (ko) * 2011-04-25 2012-11-01 Park Jun-Hyoung 탈모방지 및 발모촉진용 외용제 조성물
AU2012272804B2 (en) 2011-06-22 2017-07-06 Vyome Therapeutics Limited Conjugate-based antifungal and antibacterial prodrugs
FR2992859B1 (fr) * 2012-07-09 2014-10-03 Fabre Pierre Dermo Cosmetique Utilisation de coceth sulfate de zinc comme agent antibacterien vis a vis de propionibacterium acnes
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
BR102012022036B1 (pt) * 2012-08-31 2019-10-01 Biolab Sanus Farmacêutica Ltda. Nanopartícula polimérica de finasterida e minoxidil, processo de sua preparação, suspensão aquosa contendo a mesma, composição farmacêutica, e seu uso
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
CA2905121C (en) 2013-03-12 2021-10-26 Mary Kay Inc. Preservative system
TWI593411B (zh) * 2013-04-30 2017-08-01 徐懷山 組合物於製備抑制雄性素受體有關之功能及治療雄性素 受體相關之疾病的藥物之用途
WO2014184173A1 (en) * 2013-05-14 2014-11-20 Montero Gida Sanayi Ve Ticaret A.S. Hair care formulations
MX2015016675A (es) 2013-06-04 2016-07-15 Vyome Biosciences Pvt Ltd Particulas recubiertas y composiciones que comprenden las mismas.
US9011934B2 (en) * 2013-06-14 2015-04-21 SatisPharma, LLC Multi-purpose anti-itch treatment
EP2829303A1 (en) * 2013-07-22 2015-01-28 Johnson & Johnson Consumer Companies Inc. Compositions comprising extract of malva neglecta and method of treating a skin condition with malva neglecta
JP2016529317A (ja) 2013-09-05 2016-09-23 ザ プロクター アンド ギャンブル カンパニー 頭皮ケア組成物
CA2933367A1 (en) * 2013-12-13 2015-06-18 Restorsea, Llc Exfoliative hair retention-promoting formulation
US9522189B2 (en) 2013-12-20 2016-12-20 Johnson & Johnson Consumer Inc. Topical gel compositions including poly(monostearoyl glycerol-co-succinate) polymer and methods for enhancing the topical application of a benefit agent
US20150174254A1 (en) 2013-12-23 2015-06-25 Mcneil-Ppc, Inc. Topical gel compositions including polycaprolactone polymer and methods for enhancing the topical application of a benefit agent
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
US9474699B2 (en) 2014-03-31 2016-10-25 Johnson & Johnson Consumer Inc. Compostions and methods for enhancing the topical application of a basic benefit agent
US9468606B2 (en) 2014-03-31 2016-10-18 Johnson & Johnson Consumer Inc. Compostions and methods for enhancing the topical application of an acidic benefit agent
JP2017511347A (ja) * 2014-04-24 2017-04-20 ザ プロクター アンド ギャンブル カンパニー 頭皮ケア組成物
MX2016014982A (es) 2014-05-16 2017-03-31 Restorsea Llc Cosmetico bifasico.
US11696883B2 (en) 2014-05-23 2023-07-11 Triple Hair Inc. Compositions for reducing hair loss and/or increasing hair regrowth
PL3062797T3 (pl) 2014-05-23 2020-08-24 Triple Hair Inc. Kompozycje zmniejszające wypadanie włosów i/lub zwiększające odrastanie włosów
RU2017101050A (ru) 2014-06-16 2018-07-16 Джонсон энд Джонсон Консьюмер Инк. Композиции и способы повышения эффективности местного нанесения окрашенного косметического средства
WO2015195304A1 (en) 2014-06-17 2015-12-23 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for enhancing the topical application of a benefit agent including powder to liquid particles and a second powder
US9675537B2 (en) * 2014-06-30 2017-06-13 Johnson & Johnson Consumer Inc. Hair growth composition and method
US9452178B1 (en) 2014-10-22 2016-09-27 SatisPharma, LLC Acne formulations, treatments, and pressure sensitive patches for delivery of acne formulations
CN107530251A (zh) * 2014-10-24 2018-01-02 美特派有限责任公司 组合的毛发脱落抑制治疗
EP3236903B1 (en) 2014-12-23 2021-04-21 Intellectual Property Associates, LLC Methods and formulations for transdermal administration
US9351945B1 (en) * 2015-02-27 2016-05-31 John Daniel Dobak, III Reduction of adipose tissue
CA2958794C (en) 2015-07-08 2018-10-23 Triple Hair Inc. Composition comprising resveratrol and melatonin for reducing hair loss and/or increasing hair regrowth
US10130578B2 (en) * 2015-07-23 2018-11-20 Johnson & Johnson Consumer Inc. Topical delivery of skin compositions having low pH
CN108136166A (zh) * 2015-09-22 2018-06-08 强生消费者公司 用于增强有益剂的局部应用的装置和方法
JP2017078044A (ja) * 2015-10-21 2017-04-27 大正製薬株式会社 発毛剤組成物
US11666520B2 (en) 2015-12-28 2023-06-06 Johnson & Johnson Consumer Inc. Hair growth composition and method
US9962444B2 (en) 2016-09-27 2018-05-08 Shane Malek Pharmacokinetically extended action topical hair growth formulation, and administration method
RU2760374C2 (ru) 2016-12-23 2021-11-24 Р.П. Шерер Текнолоджис, Ллс Матрица для мягких гелевых капсул с несколькими наполнителями/отделениями
WO2018206077A1 (en) * 2017-05-08 2018-11-15 Merz Pharma Gmbh & Co. Kgaa Emulsion comprising finasteride
CN107281185B (zh) * 2017-06-16 2018-08-17 曹凡 一种促进毛发生长的乳化组合物及其制备方法
EP3418365A1 (en) 2017-06-19 2018-12-26 The Procter & Gamble Company Automatic dishwashing cleaning composition
WO2019070142A2 (en) * 2017-10-08 2019-04-11 Qatar Pharma For Pharmaceuticals Industries TOPICAL LOTION FOR THE TREATMENT OF THE HAIR FALL (BIOHAIR®)
WO2019096635A1 (en) * 2017-11-16 2019-05-23 Dsm Ip Assets B.V. Topical compositions
JP2019210268A (ja) * 2018-05-30 2019-12-12 ダイヤ製薬株式会社 外用剤及び外用剤の製造方法
CN110604741A (zh) * 2018-06-15 2019-12-24 瑞恩生化科技有限公司 抑制皮肤细胞增生的组合物及其应用
CN108743422A (zh) * 2018-06-27 2018-11-06 天津静瀛高新科技有限公司 广谱灭菌型洗发露及其制造方法
US10463596B1 (en) 2018-06-28 2019-11-05 The Procter And Gamble Company Scalp care composition with well dispersed particulate scalp benefit agents
WO2022125405A1 (en) 2020-12-07 2022-06-16 O&M Halyard, Inc. Damp hand donning and moisturizing glove
CN115475168B (zh) * 2022-10-18 2024-02-13 湖北工业大学 含米诺地尔的药物组合物及其制备方法和应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139619A (en) 1976-05-24 1979-02-13 The Upjohn Company 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth
US4596812A (en) 1976-05-24 1986-06-24 The Upjohn Company Methods and solutions for treating male pattern alopecia
AU8025787A (en) 1986-09-12 1988-04-07 Upjohn Company, The Foams for delivery of minoxidil
JPH03236317A (ja) * 1989-12-06 1991-10-22 Sansei Seiyaku Kk ドパミン誘導体含有経皮用製剤
WO1992003123A1 (en) * 1990-08-28 1992-03-05 Liposome Technology, Inc. Liposome alternative bilayer formulations
US5152997A (en) 1990-12-11 1992-10-06 Theratech, Inc. Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels
JPH069394A (ja) * 1992-06-25 1994-01-18 Lion Corp 外用消炎鎮痛液剤
DE4330597A1 (de) 1992-10-14 1995-03-16 Ahmad Khalil Haarwuchssystem und Haarwasser gegen Haarausfall
WO1994021262A1 (en) 1993-03-17 1994-09-29 Alza Corporation Device for the transdermal administration of alprazolam
JPH072677A (ja) 1993-06-18 1995-01-06 Toyo Seito Kk 経口育毛剤
JP3520936B2 (ja) * 1993-12-07 2004-04-19 大正製薬株式会社 育毛剤
JPH07233088A (ja) * 1993-12-27 1995-09-05 Takeda Chem Ind Ltd 局所外用剤
US5629021A (en) * 1995-01-31 1997-05-13 Novavax, Inc. Micellar nanoparticles
US5945409A (en) * 1995-03-10 1999-08-31 Wilson T. Crandall Topical moisturizing composition and method
JPH0948740A (ja) * 1995-08-04 1997-02-18 Pola Chem Ind Inc 選択的薬物吸収促進剤
JPH0971513A (ja) 1995-09-07 1997-03-18 Taisho Pharmaceut Co Ltd 育毛剤
JPH0987148A (ja) * 1995-09-21 1997-03-31 Suntory Ltd 育毛組成物
JPH09268123A (ja) * 1996-03-30 1997-10-14 Nichiban Co Ltd 局所麻酔用貼付剤
JPH09278651A (ja) * 1996-04-05 1997-10-28 Sekisui Chem Co Ltd 経皮吸収貼付剤
US5837289A (en) * 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers

Also Published As

Publication number Publication date
CO5080786A1 (es) 2001-09-25
CN1303263A (zh) 2001-07-11
TWI257310B (en) 2006-07-01
US6284234B1 (en) 2001-09-04
AU5669599A (en) 2000-02-28
WO2000007627A2 (en) 2000-02-17
CA2339231A1 (en) 2000-02-17
WO2000007627A8 (en) 2001-02-08
EP1104280A2 (en) 2001-06-06
US6419913B1 (en) 2002-07-16
WO2000007627A3 (en) 2000-08-17
JP2003521452A (ja) 2003-07-15
US20020048558A1 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
AR019997A1 (es) Sistema de administracion topica para agentes activos
EP1060732A3 (en) Novel topical formulations comprising vesicle delivery systems
ES2232977T3 (es) Composiciones y metodo para el tratamiento de la alopecia.
ES2160631T5 (es) Utilizacion de agentes tensioactivos no ionicos en composiciones estables de retinoides para aplicacion topica.
AR019588A1 (es) Una composicion para el tratamiento capilar
AR007542A1 (es) Composicion
US8288434B2 (en) Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
AR013225A1 (es) Metodos y composiciones contra lineas finas y/o arrugas
BR9913154A (pt) Composição de musse
RS20060479A (en) Novel compositions for topical delivery
AR023062A1 (es) Formulaciones antiparasitarias
AR007582A1 (es) Composicion para el lavado de la piel, procedimiento para prepararla y el uso de la misma para la fabricacion de medicamentos dado el caso, para eltratamiento cosmetico de la piel.
ES2622402T3 (es) Combinación de antioxidantes en una composición de uso dermatológico y/o cosmético
JP2008542251A (ja) レスベラトロルを含む組成物及び人間の発毛の低減のためのその局所的使用
KR100864129B1 (ko) 여드름 치료를 위한 국소 답손
KR20160090754A (ko) 산화염모제 제1 제 및 산화염모제 조성물의 색조 안정화 방법
ES2137125B1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
MX2021015830A (es) Formulaciones penetrantes transdermicas.
JP2005505528A (ja) オルニチンデカルボキシラーゼインヒビターの毛包輸送のための局所用組成物
DK1194109T3 (da) Topiske formuleringer omfattende hud-gennemtrængningsmidler samt anvendelse deraf
JP2006507317A (ja) ベンゾピラン類を用いて毛成長を刺激する方法
ES2337359T3 (es) Procedimiento de exfoliacion que utiliza urea.
CS275816B6 (en) Cosmetic preparation for use on greasy skin
ES2350583T3 (es) Composición que comprende wortmanina y uso tópico de la misma para reducir el crecimiento del vello humano.
US20030138468A1 (en) Skin protective compositions